A Rubboli

Summary

Country: Italy

Publications

  1. ncbi The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy
    Intern Emerg Med 7:299-304. 2012
  2. ncbi Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry)
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Italy
    Am J Cardiol 109:1411-7. 2012
  3. ncbi The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Italy
    J Interv Cardiol 25:163-9. 2012
  4. ncbi Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose
    A Rubboli
    Division of Cardiology, Ospedale Maggiore, Bologna, Italy
    Minerva Cardioangiol 54:131-7. 2006
  5. ncbi [Antithrombotic treatment after coronary stenting in patients with an indication to oral anticoagulation: what are the possible strategies?]
    Andrea Rubboli
    U O di Cardiologia, Ospedale Maggiore, Bologna
    G Ital Cardiol (Rome) 7:68-73. 2006
  6. ncbi Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Cardiology 107:132-9. 2007
  7. ncbi Contemporary antithrombotic treatment after coronary stenting in patients with indication for long-term anticoagulation
    A Rubboli
    Division of Cardiology, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy
    Minerva Cardioangiol 54:687-93. 2006
  8. ncbi Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy, and School of Medicine, Karolinska University, Stockholm, Sweden
    Coron Artery Dis 18:193-9. 2007
  9. ncbi Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician
    Andrea Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Largo Nigrisoli 2, 40133 Bologna, Italy
    Int J Cardiol 123:234-9. 2008
  10. ncbi Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence
    A Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Intern Emerg Med 2:177-81. 2007

Detail Information

Publications38

  1. ncbi The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy
    Intern Emerg Med 7:299-304. 2012
    ....
  2. ncbi Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry)
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Italy
    Am J Cardiol 109:1411-7. 2012
    ....
  3. ncbi The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Italy
    J Interv Cardiol 25:163-9. 2012
    ..To evaluate the current management, and adherence to recommendations, of patients on oral anticoagulation (OAC) undergoing coronary stent implantation (PCI-S)...
  4. ncbi Subcutaneous enoxaparin following thrombolysis and intravenous unfractionated heparin in ST-elevation acute myocardial infarction: safety and efficacy of low vs full dose
    A Rubboli
    Division of Cardiology, Ospedale Maggiore, Bologna, Italy
    Minerva Cardioangiol 54:131-7. 2006
    ..Since optimal dosing of subcutaneous Enoxaparin is not standardized, we conducted an observational study to compare safety and efficacy of low (4,000 U once daily) vs full dose (100 U/kg twice daily) regimens...
  5. ncbi [Antithrombotic treatment after coronary stenting in patients with an indication to oral anticoagulation: what are the possible strategies?]
    Andrea Rubboli
    U O di Cardiologia, Ospedale Maggiore, Bologna
    G Ital Cardiol (Rome) 7:68-73. 2006
  6. ncbi Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Cardiology 107:132-9. 2007
    ..We aimed at evaluating the current level of evidence supporting the use of LMWH in STEMI...
  7. ncbi Contemporary antithrombotic treatment after coronary stenting in patients with indication for long-term anticoagulation
    A Rubboli
    Division of Cardiology, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy
    Minerva Cardioangiol 54:687-93. 2006
    ..The aim of this study was to evaluate the contemporary management of these patients, and determine the safety and the efficacy of the various regimens...
  8. ncbi Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy, and School of Medicine, Karolinska University, Stockholm, Sweden
    Coron Artery Dis 18:193-9. 2007
    ....
  9. ncbi Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician
    Andrea Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Largo Nigrisoli 2, 40133 Bologna, Italy
    Int J Cardiol 123:234-9. 2008
    ..Such strategy is generally not applicable in most patients with an indication for oral anticoagulation (OAC), for whom however, information about the optimal antithrombotic regimen is currently limited...
  10. ncbi Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence
    A Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Intern Emerg Med 2:177-81. 2007
    ....
  11. ncbi Utilizing enoxaparin in the management of STEMI
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Vasc Health Risk Manag 3:691-700. 2007
    ..Along with its easiness of use, not requiring laboratory monitoring, the subcutaneous administration of enoxaparin allows extended antithrombotic treatment, while permitting early mobilization (and rehabilitation) of patients...
  12. ncbi Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation
    Andrea Rubboli
    Division of Cardiology, Cardiac Catheterization Laboratory, Maggiore Hospital, Bologna, Italy
    Ann Med 40:428-36. 2008
    ..Whether the combination of warfarin and clopidogrel (without aspirin) will preserve efficacy and produce less bleeding is an important issue still needing to be addressed...
  13. ncbi [How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?]
    Andrea Rubboli
    Laboratorio di Emodinamica, U O di Cardiologia, Ospedale Maggiore, Largo Nigrisoli, 2, 40133 Bologna
    G Ital Cardiol (Rome) 9:745-52. 2008
    ..Therefore, large-scale prospective studies are needed to determine the optimal antithrombotic treatment in this patient population...
  14. ncbi A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry
    Andrea Rubboli
    Unita Operativa di Cardiologia, Ospedale Maggiore, Bologna, Italy
    J Cardiovasc Med (Hagerstown) 10:200-3. 2009
    ..As a consequence, clues for the optimal management of this patient subset will be obtained...
  15. ncbi Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting
    Andrea Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Ospedale Maggiore, Bologna, Italy
    J Interv Cardiol 22:390-7. 2009
    ..Also, the contribution of early bleeding to the relevant hemorrhagic rate reported at follow-up with triple therapy of OAC, aspirin, and clopidogrel is largely unknown...
  16. ncbi Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options
    Andrea Rubboli
    Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy
    Chest 139:981-7. 2011
    ..Discontinuation of OAC and substitution with dual antiplatelet therapy is the optimal strategy for patients at low thromboembolic risk...
  17. ncbi Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting
    Andrea Rubboli
    Cardiac Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Cardiology 104:101-6. 2005
    ..65, 3.8, 4.2, 6.4 and 6.6%, respectively. In conclusion, due to the low AR of adverse events, the combination of OAC and aspirin appears an acceptable treatment after PCI-S in patients in whom long-term OAC is deemed mandatory...
  18. ncbi Massive coronary artery calcification in a young adult with end-stage renal disease undergoing hemodialysis
    Andrea Rubboli
    Catheterization Laboratory, Cardiology Unit, San Bortolo Hospital, Vicenza, Italy
    Ital Heart J 4:142-3. 2003
  19. ncbi Association of cholesterol levels and occurrence of angiographically detectable endothelial disruption during coronary angioplasty
    Andrea Rubboli
    Catheterization Laboratory, Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Clin Cardiol 26:336-40. 2003
    ..Disruption of the atherosclerotic plaque is a common feature of both acute coronary syndromes and balloon dilatation of coronary artery stenoses...
  20. ncbi Enoxaparin for the treatment of acute myocardial infarction with persistent ST-segment elevation
    A Rubboli
    Catheterization Laboratory, Cardiology Unit, S Maria delle Croci Hospital, Ravenna, Italy
    Minerva Cardioangiol 51:463-70, 470-4. 2003
    ..Further-more, some open issues relative to the use of E in particular settings (aged patients, in association with glycoprotein IIb/IIIa inhibitors and during percutaneous coronary revascularization) need to be clarified...
  21. ncbi Outcome of percutaneous coronary angioplasty (PTCA) performed in a low-volume institution by low-volume operators, evaluated by means of the one-month major adverse cardiac event rate
    A Rubboli
    Unita Operativa di Cardiologia, Ospedale Maggiore, Bologna, Italy
    Minerva Cardioangiol 49:357-62. 2001
    ....
  22. ncbi Appropriateness of the use of coronary angiography in a population of patients with ischemic heart disease
    A Rubboli
    Cardiology Unit, Maggiore Hospital, Bologna, Italy
    Ital Heart J 2:696-701. 2001
    ..However, an inappropriate rate of its utilization has been reported in 2 to 58% of cases. The aim of our study was therefore to evaluate the appropriateness of the indications for coronary angiography at our Institution...
  23. ncbi Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Ital Heart J 5:851-6. 2004
    ..In order to investigate current practice in this setting, an international survey was carried out...
  24. ncbi Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center
    Andrea Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Ital Heart J 5:919-25. 2004
    ..The aim of our study was to determine the strategies adopted at our Institution (where the management of these patients is at the physician's discretion), and to evaluate their relative efficacy and safety...
  25. ncbi Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis
    Gianni Casella
    Cardiology Division, Maggiore Hospital, Bologna, Italy
    Ital Heart J 4:677-84. 2003
    ..The purpose of the present investigation was to update the data regarding this issue by means of a formal meta-analysis...
  26. ncbi Coronary stenting for ST-elevation myocardial infarction vs. other indications in patients on oral anticoagulation: any difference in in-hospital management and outcome?
    S Vecchio
    Division of Cardiology and Interventional Center, Santa Maria delle Croci Hospital, Ravenna, Italy
    Minerva Cardioangiol 59:499-506. 2011
    ..The aim of this paper was to compare the in-hospital management and outcome of patients on oral anticoagulation (OAC) undergoing coronary artery stenting (PCI-S) for ST-elevation myocardial infarction (STEMI) vs. other indications...
  27. ncbi Frequency and determinants of direct stenting in routine percutaneous coronary interventions: data on 835 consecutive procedures in a single center
    Luigi La Vecchia
    Catheterization Laboratory, Department of Cardiology, San Bortolo Hospital, Vicenza, Italy
    Ital Heart J 5:749-54. 2004
    ..However, the impact of direct stenting in routine interventional practice remains poorly elucidated...
  28. ncbi Systematic coronary stenting after failed thrombolysis in high-risk patients with acute myocardial infarction: procedural results and long-term follow-up
    Luigi La Vecchia
    Department of Cardiology, San Bortolo Hospital, Vicenza, Italy
    Coron Artery Dis 14:395-400. 2003
    ..However, very little information is available for patients who receive a stent after failed thrombolysis (so-called 'rescue' stenting)...
  29. ncbi Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism
    L La Vecchia
    Department of Cardiology, Ospedale S Bortolo, Vicenza, Italy
    Heart 90:633-7. 2004
    ..6 ng/ml on admission was the most powerful predictor of mortality (p = 0.046). CONCLUSIONS: In high risk patients with acute PE, cTnI was frequently detected on admission. It was the strongest independent predictor of mortality...
  30. ncbi Current perspectives The diagnosis of acute pulmonary embolism. A review of the literature and current clinical practice
    A Rubboli
    Division of Cardiology, Maggiore Hospital, Bologna, Italy
    Ital Heart J 1:585-94. 2000
    ....
  31. ncbi [Relation between cardiology and cardiosurgery in a center without cardiosurgery: an organizational proposal in the coronary syndromes]
    Gianni Casella
    U O di Cardiologia, U O di Rianimazione 118, Ospedale Maggiore
    Ital Heart J Suppl 3:319-30. 2002
    ..However, the main issues of these relations as well as outcomes do not differ significantly whether heart surgery is on-site or off-site...
  32. ncbi Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry)
    Luigi Vignali
    Division of Cardiology, Azienda Ospedaliero Universitaria, Parma, Italy
    Am J Cardiol 101:947-52. 2008
    ..In conclusion, our data suggest that rates of 12-month MACEs associated with the use of DESs and BMSs are similar in patients undergoing treatment of de novo lesions in SVGs...
  33. ncbi Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolism
    Tania Chechi
    Division of Cardiology, Cardiologia e Cardiologia Invasiva 2, A O U Careggi, Florence, Italy
    Catheter Cardiovasc Interv 73:506-13. 2009
    ..To appraise the impact of AngioJet rheolytic thrombectomy (RT) on angiographic and clinical endpoints in patients with acute pulmonary embolism (PE)...
  34. ncbi The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation
    Andrea Rubboli
    Eur Heart J 27:2908-9; author reply 2909-10. 2006
  35. ncbi Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulation
    Andrea Rubboli
    Am Heart J 149:E1. 2005
  36. ncbi Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy
    Andrea Rubboli
    Ital Heart J 6:405-8. 2005
  37. ncbi Antonio Maria Valsalva
    Sven Göran Fransson
    Department of Thoracic Radiology, University Hospital, Linkoping, Sweden
    Clin Cardiol 26:102-3. 2003
  38. ncbi More about transport for primary PCI in AMI
    Andrea Rubboli
    Eur Heart J 25:708. 2004